JY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALL
Clinical trial NCT07406178 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07406178
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-20
- Primary completion
- 2029-01-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.